Search research articles
Contact Us
Filters
Showing results (91-100 of 147) with videos related to
Page
of 15
Sort By:
Actas Dermo-Sifiliograficas
|
March 18, 2015
Risk of Reactivation of Hepatitis B Virus Infection in Psoriasis Patients Treated With Biologics: A Retrospective Analysis of 20 Cases From the BIOBADADERM Database
J Sanz-Bueno, F Vanaclocha, I García-Doval, et al.
Gut
|
May 20, 2006
Spectrum of gluten-sensitive enteropathy in first-degree relatives of patients with coeliac disease: clinical relevance of lymphocytic enteritis
M Esteve, M Rosinach, F Fernández-Bañares, et al.
ACS Omega
|
October 2, 2023
Synthesis of Novel Heterocyclic Ferrocenyl Chalcones and Their Biological Evaluation
Ámbar M Alsina-Sánchez, Sebastián Montalvo-Vázquez, Nilmary Grafals-Ruiz, et al.
Circulation
|
April 20, 2018
Rearrangement of the Protein Phosphatase 1 Interactome During Heart Failure Progression
David Y Chiang, Katherina M Alsina, Eleonora Corradini, et al.
Journal of Cellular Physiology
|
November 30, 2018
Ranolazine prevents pressure overload-induced cardiac hypertrophy and heart failure by restoring aberrant Na<sup>+</sup> and Ca<sup>2+</sup> handling
Jiali Nie, Quanlu Duan, Mengying He, et al.
Actas Dermo-Sifiliograficas
|
March 8, 2011
[BIOBADADERM, the Spanish Registry of Adverse Events Associated with Biologic Drugs in Dermatology: first report]
R Rivera, I García-Doval, G Carretero, et al.
ESMO Open
|
August 9, 2021
Quality of life with first-line pembrolizumab for PD-L1-positive advanced gastric/gastroesophageal junction adenocarcinoma: results from the randomised phase III KEYNOTE-062 study
E Van Cutsem, A Valderrama, Y-J Bang, et al.
ESMO Open
|
June 27, 2021
Trifluridine/tipiracil versus placebo for third or later lines of treatment in metastatic gastric cancer: an exploratory subgroup analysis from the TAGS study
J Tabernero, K Shitara, A Zaanan, et al.
British Journal of Haematology
|
October 6, 2004
A phase 2 study of two doses of bortezomib in relapsed or refractory myeloma
S Jagannath, B Barlogie, J Berenson, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
March 18, 2014
Use of biological treatments in patients with hidradenitis suppurativa
G Martin-Ezquerra, E Masferrer, M Masferrer-Niubò, et al.
Page
of 15
Search research articles
Search
Showing results (91-100 of 147) with videos related to
Sort By:
Page
of 15
Actas Dermo-Sifiliograficas
|
March 18, 2015
Risk of Reactivation of Hepatitis B Virus Infection in Psoriasis Patients Treated With Biologics: A Retrospective Analysis of 20 Cases From the BIOBADADERM Database
J Sanz-Bueno, F Vanaclocha, I García-Doval, et al.
Gut
|
May 20, 2006
Spectrum of gluten-sensitive enteropathy in first-degree relatives of patients with coeliac disease: clinical relevance of lymphocytic enteritis
M Esteve, M Rosinach, F Fernández-Bañares, et al.
ACS Omega
|
October 2, 2023
Synthesis of Novel Heterocyclic Ferrocenyl Chalcones and Their Biological Evaluation
Ámbar M Alsina-Sánchez, Sebastián Montalvo-Vázquez, Nilmary Grafals-Ruiz, et al.
Circulation
|
April 20, 2018
Rearrangement of the Protein Phosphatase 1 Interactome During Heart Failure Progression
David Y Chiang, Katherina M Alsina, Eleonora Corradini, et al.
Journal of Cellular Physiology
|
November 30, 2018
Ranolazine prevents pressure overload-induced cardiac hypertrophy and heart failure by restoring aberrant Na<sup>+</sup> and Ca<sup>2+</sup> handling
Jiali Nie, Quanlu Duan, Mengying He, et al.
Actas Dermo-Sifiliograficas
|
March 8, 2011
[BIOBADADERM, the Spanish Registry of Adverse Events Associated with Biologic Drugs in Dermatology: first report]
R Rivera, I García-Doval, G Carretero, et al.
ESMO Open
|
August 9, 2021
Quality of life with first-line pembrolizumab for PD-L1-positive advanced gastric/gastroesophageal junction adenocarcinoma: results from the randomised phase III KEYNOTE-062 study
E Van Cutsem, A Valderrama, Y-J Bang, et al.
ESMO Open
|
June 27, 2021
Trifluridine/tipiracil versus placebo for third or later lines of treatment in metastatic gastric cancer: an exploratory subgroup analysis from the TAGS study
J Tabernero, K Shitara, A Zaanan, et al.
British Journal of Haematology
|
October 6, 2004
A phase 2 study of two doses of bortezomib in relapsed or refractory myeloma
S Jagannath, B Barlogie, J Berenson, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
March 18, 2014
Use of biological treatments in patients with hidradenitis suppurativa
G Martin-Ezquerra, E Masferrer, M Masferrer-Niubò, et al.
Page
of 15